pigment disorders spotted disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Melasma and postinflammatory hyperpigmentation : skin photo type I-V ; Becker naevus: skin photo type I-III ; Ochronosis and ashy dermatosis : skin photo type IV-V ; resistant Ota naevus: skin photo type III-IV ; Subjects attending the outpatient department of the Netherlands Institute for Pigment Disorders; Age at least 18 years; Subject is willing and able to give written informed consent.
Exclusion criteria
Exclusion criteria: Bleaching cream during the past 6 weeks; Local corticosteroids during the past 6 weeks; Subjects with a history of keloid; Subjects with active eczema; Subjects with active acne in the face; Subjects with a history of facial eczema; Suspect allergy to lidocaine or triple therapy; Use of roaccutane in the past 6 months; Subjects not competent to understand what is involved; Pregnancy; Lesion suspicious for malignancy; High exposure to sunlight (vacation in southern countries) or UV light (UVA or UVB).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Objective colour measurements by physician*s global assessment (PhGA), reflectance spectroscopy, clinical melasma score (MASI), patient*s satisfaction, patient*s global assessment (PGA), and visual assessment of side effects. | — |
Secondary
| Measure | Time frame |
|---|---|
| - | — |
Countries
Netherlands